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The current study provides a comprehensive overview and analysis of the lignan literature.
Data for the current study were extracted from the electronic Web of Science Core
Collection database via the search string TOPIC = (“lignan*”) and processed by the
VOSviewer software. The search yielded 10,742 publications. The ratio of original articles
to reviews was 14.6:1. Over 80% of the analyzed papers have been published since the
year 2000 and nearly 50% since the year 2010. Many of the publications were focused on
pharmacology, chemistry, and plant sciences. The United States and Asian countries,
such as China, Japan, South Korea, and India, were the most productive producers of
lignan publications. Among the 5 most productive institutions was the University of
Helsinki in Finland, the country that ranked 9th. Nineteen journals collectively published
3,607 lignan publications and were considered as core journals. Their impact factor did
not correlate with the proportion of uncited papers. Highly cited publications usually
mentioned phytoestrogen, isoﬂavone, daidzein, enterodiol, enterolactone, equol,
genistein, and isoﬂavonoid. Cancer (e.g., breast cancer), cardiovascular disease, and
antioxidation were the major themes. Clinical trials were estimated to contribute to 0.2–
1.1% of the analyzed body of literature, so more of them should be conducted in the future
to substantiate the beneﬁcial effects and optimal dose of lignan intake in humans.
Moreover, researchers can refer to these ﬁndings for future research directions
and collaborations.
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Yeung et al. Lignans: Quantitative Analysis of the Research LiteratureINTRODUCTION
The current study aimed to perform a quantitative analysis on
the literature of lignans to unveil the major contributors in terms
of institutions, countries/regions, and journals. By analyzing the
publication and citation data, the major research themes present
in the lignan literature were identiﬁed and further discussed.
Lignans are 1,4-diarylbutan compounds derived from the
shikimic acid biosynthetic pathway (Lewis and Davin, 1999;
Imai et al., 2006). In the 1970s, it was still commonly believed
that lignans were synthesized in plants only (Hartwell, 1976). It
was only in the 1980s when scientists identiﬁed lignans produced
by microbes living in humans and animals (Axelson et al., 1982).
Geographically, the intakes are greater in the European
population relative to the Asian population (Bhakta et al., 2006).
The main common dietary lignans are secoisolariciresinol,
lariciresinol, matairesinol, pinoresinol, medioresinol, and
syringaresinol (Durazzo et al., 2018); the range of components is
very wide and efforts on isolation of new compounds are being
carried out (Eklund and Raitanen, 2019; Xiao et al., 2019). Plant
lignans are metabolized to enterodiol and enterolactone, called
enterolignans or mammalian lignans (Landete, 2012).
The recent work of Durazzo et al. (2018) well summarized the
occurrence of lignans in food groups and existing lignan databases at
European level. As reported byDurazzo et al. (2018), themain sources of
dietary lignans are oilseeds such asﬂax, soy, rapeseed, and sesame; whole-
grain cereals such as wheat, oats, rye, and barley; legumes; various
vegetables and fruits (particularly berries); beverages (i.e., coffee, tea, and
wine); and, recently, lignans are also determined in dairy products, meat,
and ﬁsh (Valsta et al., 2003; Milder et al., 2005a; Milder et al., 2005b;
Peñalvo et al., 2005; Thompson et al., 2006; Penalvo et al., 2007; Kuhnle
et al., 2008a; Kuhnle et al., 2008b; Durazzo et al., 2009; Kuhnle et al.,
2009a; Kuhnle et al., 2009b; Smeds et al., 2009; Moreno-Franco et al.,
2011; Smeds et al., 2012; Durazzo et al., 2013a; Durazzo et al., 2013b;
Mulligan et al., 2013; Durazzo et al., 2014b; Turfani et al., 2017; Angeloni
et al., 2018; Angeloni et al., 2019).
Within the bioactive compounds realm (Santini et al., 2018;
Santini and Novellino, 2018; Daliu et al., 2019; Durazzo et al., 2019),
the class of lignans is of interest for their potential biological
activities, i.e., estrogenic and antiestrogenic, antioxidant, anti-
inﬂammatory, metabolism-modulating, anti-proliferative, and
anticancerogenic properties (Baumgartner et al., 2011; Teponno
et al., 2016; Wang et al., 2016; Linder et al., 2019; Zálešák et al.,
2019). Moreover, it is worth mentioning that the spectrum of
biological activities attributed to lignans is being enlarged, i.e.,
related to newly discovered compounds belonged to this group
(Zhang et al., 2014; Gnabre et al., 2015; Su and Wink, 2015;
Hongthong et al., 2016; Azam et al., 2019; Zhuang et al., 2019).
Several studies showed that consumption of lignan-rich diets,
which contain vegetables, fruits, and whole grain products, may
protect against chronic diseases, particularly hormone-dependent
cancer and cardiovascular diseases (Ward et al., 2009; Peterson et al.,
2010; Buck et al., 2011; Guglielmini et al., 2012; Penalvo and López-
Romero, 2012; Zamora-Ros et al., 2012; Lowcock et al., 2013;
Durazzo et al., 2014a; Rodríguez-García et al., 2019). ProperFrontiers in Pharmacology | www.frontiersin.org 2evaluation of adherence, efﬁcacy, and communication aspects
should be taken into account as well as the retrospective analysis
of databases as per recent studies in the ﬁeld (Iolascon et al., 2016;
Scala et al., 2016; Guerriero et al., 2017; Menditto et al., 2018).
The overview presented in the current study should be helpful
to readers in better understanding the lignan research
community, identifying potential research directions and
collaboration partners, and conducting more in-depth
literature searches of chemicals/chemical classes of interest.MATERIALS AND METHODS
In July 2019, we queried the Web of Science (WoS) Core Collection
online database, owned by Clarivate Analytics, to identify lignan
publications with the following search string: TOPIC = (“lignan*”).
This search identiﬁed publications mentioning the word “lignan” or
its derivatives in the title, abstract, or keywords. No additional ﬁlters
were placed on the search.
Data Extraction
Several aspects of each publication identiﬁed from the search
were recorded, namely: (1) publication year; (2) institutions; (3)
countries/regions of the institutions; (4) journal title; (5) WoS
journal category; (6) type of publication; (7) language; and (8)
number of total citations received. By using the “Export Records
to File” function of WoS, full records and cited references of the
identiﬁed publications were exported as “tab-delimited text ﬁles”
to VOSviewer for additional processing.
The VOSviewer software (v.1.6.11, 2019) was used to analyze
the titles and abstracts of publications, by breaking down the
paragraphs into words and phrases, associating them with the
citation data of the publications, and presenting the results in
the form of a bubble map (Van Eck and Waltman, 2009). Default
parameterswere used for the analyses andvisualizations. The size of
a bubble represents the frequency of appearance of a term (multiple
appearances of a word counted once, single use of the sameword in
a paper equally weighted). Two bubbles are positionedmore closely
to each other if the terms co-appeared more often in the analyzed
publications. The color represents the averaged citations per
publication (CPP). To simplify the bubble map, we analyzed and
visualized words that appeared in at least 1% (n = 108) of
the publications.
Apart from analyzing the whole dataset, we additionally
probed into the articles published by the most proliﬁc journals
to see how many of them were uncited. According to Bradford's
law of scattering, the core journals for a body of literature are
deﬁned as the proliﬁc journals that collectively published 1/3 of
the papers (Vickery, 1948). Using the current analyzed dataset,
we tested if the core journals had their impact factor negatively
correlated to the proportion of uncited papers, which was
previously demonstrated in another ﬁeld (Yeung, 2019).
Pearson's correlation test was performed using SPSS 25.0
(IBM, New York, USA). Test results were signiﬁcant if p < 0.05.February 2020 | Volume 11 | Article 37
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The literature search resulted in 10,742 publications. The earliest
publications on lignans indexed in WoS were published in 1970,
which isolated new lignans at that time and identiﬁed their
structures (Corrie et al., 1970). Over 80% of the analyzed papers
have been published since the year 2000, and nearly 50% since the
year 2010. The numbers of original articles (n = 9,422) and reviews
(n = 644) were in the ratio of 14.6:1. Reviews were more cited (CPP =
56.8) than original articles (CPP = 22.5). The majority of the
publications were written in English (n = 10,483; 97.6%).
Contributions came from 4,748 institutions located in 141
countries/regions and were published in 1,509 journals. The top
ﬁve contributors with regard to WoS category, journal, institution,
and country/region are listed in Table 1. It is worth mentioning that
Molecules was the 6th most productive journal, with 208 lignan
publications (1.9%) and CPP of 11.9. Nineteen journals collectively
published 3,607 lignan publications and were considered as core
journals (Table 2). Their impact factor did not correlate with the
proportion of uncited papers (r = -0.257, p = 0.289). Though
University of Helsinki was among the top 5 most productive
institutions, Finland was ranked 9th in terms of countries/regions
(n = 437, 4.1%). The 5most productive countries were all fromAsia,
except the United States.
There were 311 terms that appeared in at least 1% (n = 108) of
the 10,742 lignan publications (Figure 1). The highly cited
publications usually mentioned phytoestrogen (4.3%, n = 463,
CPP = 64.6), isoﬂavone (3.6%, n = 391, CPP = 64.9), or related
terms such as daidzein (2.3%, n = 243, CPP = 84.1), enterodiol
(2.6%, n = 280, CPP = 51.4), enterolactone (4.6%, n = 496, CPP =
48.0), equol (1.5%, n = 158, CPP = 82.3), genistein (2.4%, n = 260,
CPP = 84.2), and isoﬂavonoid (1.2%, n = 134, CPP = 99.8). These
terms were often mentioned together with cancer (6.1%, n = 655,
CPP = 51.8), breast cancer (2.2%, n = 237, CPP = 51.8), or
cardiovascular disease (1.5%, n = 157, CPP = 61.9). Some of the
main common dietary lignans were frequently mentioned, such as
lariciresinol (1.4%, n = 147; CPP = 27.3), matairesinol (2.5%, n =
264; CPP = 44.1), pinoresinol (3.4%, n = 368; CPP = 30.1),
secoisolariciresinol (2.6%, n = 279; CPP = 36.9), syringaresinol
(1.4%, n = 146; CPP = 23.1). The structures of these chemicals are
shown in Figure 2. The top 20 recurring terms are listed in Table 3.
The keywords listed by authors and WoS (KeyWords Plus)
were collectively analyzed. There were 88 keywords that
appeared in at least 1% (n = 108) of the lignan publications,
and the 20 most common ones are listed in Table 4. The
keywords suggested that antioxidation (4.3%) and apoptosis
(3.2%) were two frequently investigated themes, and that in
vitro (5.0%) studies were prevalent.
To analyze the temporal changes in the keywords, we
separately assessed lignan publications in three time periods:
1990s and before, 2000s, and 2010s. The top 20 recurring
keywords for each of the three periods are listed in Table 5.
Antioxidant activity rose to popularity since the 2000s.
Apoptosis, cytotoxicity, and oxidative stress became popular in
the 2010s.Frontiers in Pharmacology | www.frontiersin.org 3TABLE 1 | The top ﬁve contributors in terms of Web of Science category,
journal, institution, and country/region of publications concerning lignans.
Contributor
Publication count
(% of total)
Citation per
manuscript
Web of Science category
Pharmacology pharmacy 2,522 (23.5%) 20.5
Chemistry medicinal 2,520 (23.5%) 18.9
Plant sciences 2,050 (19.1%) 22.9
Biochemistry molecular biology 1,796 (16.7%) 24.8
Chemistry multidisciplinary 1,509 (14.0%) 16.3
Journal
Phytochemistry 587 (5.5%) 31
Journal of Natural Products 345 (3.2%) 27.1
Planta Medica 332 (3.1%) 18.9
Chemical and Pharmaceutical Bulletin 266 (2.5%) 28.4
Journal of Agricultural and Food
Chemistry
213 (2.0%) 54.5
Organization
Chinese Academy of Sciences 473 (4.4%) 13.8
University of Helsinki 246 (2.3%) 81.9
Chinese Academy of Medical Sciences
Peking Union Medical College
195 (1.8%) 14.0
Kunming Institute of Botany 193 (1.8%) 12.9
Universidade de Sao Paulo 186 (1.7%) 18.1
Country/Territory
China 2,482 (23.1%) 13.0
United States 1,321 (12.3%) 41.2
Japan 1,305 (12.1%) 24.5
South Korea 691 (6.4%) 15.5
India 638 (5.9%) 16.5February 2020 | VolumeTABLE 2 | Core journals publishing lignan papers.
Journal Impact
factor
Proportion of
uncited
lignan papers (in %)
Phytochemistry 2.905 1.5
Journal of Natural Products 4.257 1.4
Planta Medica 2.746 17.8
Chemical & Pharmaceutical Bulletin 1.405 0.8
Journal of Agricultural and Food
Chemistry
3.571 3.8
Molecules 3.060 15.9
Tetrahedron Letters 2.259 1.1
Tetrahedron 2.379 1.8
Natural Product Research 1.999 13.7
Journal of Organic Chemistry 4.745 3.4
Fitoterapia 2.431 13.4
Biochemical Systematics and Ecology 1.127 12.1
Journal of Ethnopharmacology 3.414 2.5
Journal of Asian Natural Products
Research
1.170 7.1
Bioorganic & Medicinal Chemistry Letters 2.448 2.8
Food Chemistry 5.399 4.8
Phytochemistry Letters 1.338 15.8
Bioscience, Biotechnology, and
Biochemistry
1.297 3.2
Archives of Pharmacal Research 2.458 5.411 | Article 37
Yeung et al. Lignans: Quantitative Analysis of the Research LiteratureFIGURE 1 | Bubble map visualizing words from titles and abstracts of the 10,742 lignan publications. VOSviewer software was used to evaluate the recurring terms.
Only the 311 terms that appeared in at least 1% (n = 108) of the publications were analyzed and visualized. The size of a bubble represents the frequency of
appearance of a term (multiple appearances within one publication were treated as one appearance). Two bubbles are positioned more closely to each other if the
terms co-appeared more often. The color represents the averaged citations per publication.FIGURE 2 | Chemical structures of key single phytochemicals or representatives of chemical classes that were often discussed in the evaluated lignan publications. In
parentheses are the cited compound classes (italic), number of publications (n), and citations per publication (CPP) for each chemical or representative chemical class.Frontiers in Pharmacology | www.frontiersin.org February 2020 | Volume 11 | Article 374
Yeung et al. Lignans: Quantitative Analysis of the Research LiteratureDISCUSSION
The current literature analysis on lignan publications revealed
the large publication shares from Asian countries, which were
consistent with related bodies of literature such as antioxidants
and curcumin (Yeung et al., 2019b; Yeung et al., 2019c).
Examples of some highly cited original research papers
recently published by Asian teams in the 2010s, without
international collaborations, are discussed here. For instance, a
Chinese paper reported results from sesame transcriptomes that
provide useful information for understanding the relevant lignan
biosynthesis molecular mechanism (Wei et al., 2011). AnotherFrontiers in Pharmacology | www.frontiersin.org 5Chinese team tested the effects of new lignans and neolignans on
inhibiting nitric oxide production in mouse macrophages and
against serum deprivation-induced PC12 cell damage (Xiong
et al., 2011). These papers received over 100 citations.
Meanwhile, Korean teams published the anti-inﬂammatory
effects of several lignans isolated from Schiandra chinensis (Oh
et al., 2010), and the hepatoprotective effect of pinoresinol
isolated from Forsythiae Fructus (Kim et al., 2010). These
papers were cited over 50 times. In Japan, a randomized
controlled trial was conducted, and results found that oral
intake of ﬂaxseed (Linum usitatissimum L.) lignan could lower
blood cholesterol level and risk of hepatic diseases in
hypercholesterolemic men (Fukumitsu et al., 2010). Another
Japanese team described an efﬁcient synthetic route to
synthesize herbindoles as naturally occurring forms (Saito
et al., 2012). In India, researchers extracted, separated, and
characterized sesame oil lignan (Reshma et al., 2010) and
reported a phylogenetic analysis of L. usitatissimum L.
(Barvkar et al., 2012). These Japanese and Indian papers had
around 40 citations each. All these examples demonstrate the
variety of the lignan research ﬁeld, which ranged from basic
sciences to human clinical trials.
Similar to the related research ﬁelds of berries, dietary natural
products, and functional foods (Yeung et al., 2018a; Yeung et al.,
2018b; Yeung et al., 2019d), the bubble map suggested that
cancer and cardiovascular diseases were highly cited topics for
lignan research. Readers can refer to comprehensive reviews on
the relationship between phytoestrogens (such as lignans and
isoﬂavonoids) and Western diseases (such as breast cancer and
coronary heart disease) (Adlercreutz and Mazur, 1997; Rietjens
et al., 2017). Their modulatory effects on steroid biosynthetic
enzymes, hormone concentrations, and cellular events seem to
be beneﬁcial against cancer development (Adlercreutz and
Mazur, 1997; Rietjens et al., 2017). In the early 1990s, a
Finnish-Japanese collaboration probed into the low mortality
in hormone-dependent cancer among the Japanese and found
that they had high intake of soybean products rich in
phytoestrogens, as demonstrated by a high concentration of
isoﬂavonoids (and lignans to a lesser extent) excreted in their
urine (Adlercreutz et al., 1991). In the year 1997, a case-control
study published in Lancet reported that a high intake of
phytoestrogens particularly lignan enterolactone and isoﬂavone
equol could substantially reduce breast cancer risk in women
(Ingram et al., 1997). Later, another paper reviewed data on
existing epidemiologic studies and suggested that lignans and
ﬂavonoids have beneﬁcial effects on cardiovascular diseases and
lung cancer, but not other cancers (Arts and Hollman, 2005).
The issues of low bioavailability might partly explain the
differences in the results obtained between studies using cell/
animal models and humans, particularly for the anti-cancer
effects (Yang et al., 2001).
In addition, the bubble map can also relate to some of the
potential biological activities of lignans, e.g., estrogenic and
antiestrogenic, antioxidant, anti- inﬂammatory, and
anticancerogenic properties (Baumgartner et al., 2011; Teponno
et al., 2016; Wang et al., 2016; Linder et al., 2019; Zálešák et al.,TABLE 3 | The top 20 recurring terms from titles and abstracts.
Term Appearance (% of 10,742 publications)
Lignan 5,700 (53.1%)
Compound 3,995 (37.2%)
Study 3,120 (29.0%)
Effect 2,878 (26.8%)
Activity 2,843 (26.5%)
Structure 2,443 (22.7%)
Analysis 2,121 (19.7%)
Acid 1,768 (16.5%)
Cell 1,629 (15.2%)
Level 1,367 (12.7%)
Concentration 1,365 (12.7%)
Synthesis 1,347 (12.5%)
Treatment 1,217 (11.3%)
Value 1,197 (11.1%)
Group 1,186 (11.0%)
Plant 1,144 (10.6%)
Addition 1,085 (10.1%)
Data 1,065 (9.9%)
Derivative 974 (9.1%)
Content 949 (8.8%)TABLE 4 | The top 20 recurring keywords.
Keyword Occurrence (% of 10,742 publications)
Lignans 3,825 (35.6%)
Lignan 1,358 (12.6%)
Constituents 1,217 (11.3%)
Derivatives 536 (5.0%)
Neolignans 536 (5.0%)
In-vitro 535 (5.0%)
Flavonoids 509 (4.7%)
Phytoestrogens 488 (4.5%)
Antioxidant activity 458 (4.3%)
Identiﬁcation 438 (4.1%)
Cells 435 (4.0%)
Leaves 433 (4.0%)
Antioxidant 399 (3.7%)
Glycosides 388 (3.6%)
Flaxseed 383 (3.6%)
Inhibition 366 (3.4%)
Enterolactone 347 (3.2%)
Apoptosis 345 (3.2%)
Acid 344 (3.2%)
Expression 334 (3.1%)February 2020 | Volume 11 | Article 37
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being identiﬁed as frequently mentioned terms, whereas they were
strong interests in phytoestrogen and cancer.
By limiting to “articles” (excluding other publication types
such as reviews), a quick query of “clinical trial*” within the
analyzed body of literature returned with 50 hits only. After
evaluation, we found that there were only 19 randomized clinical
trials, which was equivalent to 0.2% of the 10,742 lignan
publications. A follow-up search in PubMed database with a
query of “lignan*” and limited article type to “Clinical Trial”
returned with 121 hits, which was equivalent to 1.1% of the
analyzed publications. With such a small ratio of clinical trials in
the lignan research literature, we believe that more clinical trials
should be conducted to substantiate the beneﬁcial effects and
optimal dose of lignan intake on humans. In addition,
researchers are currently experiencing common difﬁculties in
estimating the dietary intakes of lignans (and also other non-
nutritive substances) because they are not routinely included in
the food composition tables, and there exists variability in
contents reactive to soil quality, sun exposure, etc. All these
complicate the works concerning the dose of lignan intake.
This study inherited some limitations, such as using indexed
data based on a single database (WoS). Furthermore, the latest
research trends, if any, might remain undetected due to a lack of
time to accumulate publication and citation counts. Similar to
previous literature analyses on curcumin and resveratrol (Yeung
et al., 2019a; Yeung et al., 2019b), we did not analyze the
authorship of the lignan publications, as there existed many
Chinese authors with similar initials that caused inaccurate
counting. Analyzing authorship by authors' full names was also
not practical, as many publication records listed author initials
only. Moreover, the analysis cannot evaluate the scientiﬁc
methods used to determine the research ﬁndings (e.g.,Frontiers in Pharmacology | www.frontiersin.org 6distinguish between in vivo work used to determine
mechanistic relationships at a molecular level, and disease
associations elucidated from population research). For an
analysis of over 10,000 publications, this requires additional
automatic labeling of the documents (data tagging), which is
currently very limited in the literature databases. For Web of
Science, for example, there are only a few publication types, e.g.,
articles, reviews, editorials. Besides, lignan sub-types and method
of action in metabolizers are not analyzed.
Overall, the current report identiﬁed the terms and themes in
the lignan research literature, being important in terms of
publication and citation data. Results revealed several recurring
or highly cited themes, implying that the bibliometric analysis
was able to quantitatively highlight the topics in the ﬁeld deemed
important by the ﬁeld experts.CONCLUSIONS
To summarize, a bibliometric analysis was conducted to evaluate
publications on lignans. The current ﬁndings revealed that the
United States and Asian countries, such as China, Japan, South
Korea, and India, were the most productive countries. Some
productive institutions were based outside these countries, such
as the University of Helsinki in Finland. Many of the
publications were focused on pharmacology (23.5%), chemistry
(23.5%), and plant sciences (19.1%). Over 80% of the analyzed
papers have been published since year 2000, and nearly 50%
since year 2010. The highly cited publications usually mentioned
speciﬁc terms such as phytoestrogen, isoﬂavone, daidzein,
enterodiol, enterolactone, equol, genistein, isoﬂavonoid, cancer,
breast cancer, or cardiovascular disease. Some frequently
mentioned and discussed main common dietary lignans wereTABLE 5 | The top 20 recurring keywords in each decade.
1990s and before Occurrence (% of 2,144) 2000s Occurrence
(% of 3,312)
2010s Occurrence
(% of 5,295)
Lignans 593 (27.7) Lignans 1,304 (39.4) Lignans 1,928 (36.4)
Lignan 192 (9.0) Lignan 467 (14.1) Constituents 708 (13.4)
Constituents 148 (6.9) Constituents 361 (10.9) Lignan 699 (13.2)
Neolignans 108 (5.0) Phytoestrogens 254 (7.7) In-vitro 366 (6.9)
Phytoestrogens 96 (4.5) Neolignans 180 (5.4) Flavonoids 324 (6.1)
Genistein 86 (4.0) Derivatives 179 (5.4) Antioxidant activity 313 (5.9)
Breast-cancer 60 (2.8) Enterolactone 157 (4.7) Antioxidant 307 (5.8)
Derivatives 60 (2.8) Flaxseed 152 (4.6) Cells 298 (5.6)
Identiﬁcation 57 (2.7) In-vitro 143 (4.3) Derivatives 297 (5.6)
Cancer 50 (2.3) Antioxidant activity 140 (4.2) Leaves 295 (5.6)
Women 48 (2.2) Flavonoids 138 (4.2) Apoptosis 272 (5.1)
Chemistry 47 (2.2) Phyto-estrogens 132 (4.0) Identiﬁcation 266 (5.0)
Flavonoids 47 (2.2) Breast-cancer 127 (3.8) Expression 253 (4.8)
Bark 46 (2.1) Inhibition 119 (3.6) Glycosides 252 (4.8)
Acid 45 (2.1) Metabolism 119 (3.6) Neolignans 248 (4.7)
Inhibition 44 (2.1) Identiﬁcation 115 (3.5) Phenolic-compounds 210 (4.0)
Podophyllotoxin 44 (2.1) Acid 114 (3.4) Oxidative stress 209 (3.9)
Diet 42 (2.0) Mammalian lignans 114 (3.4) Flaxseed 203 (3.8)
Estrogens 42 (2.0) Cells 113 (3.4) Inhibition 203 (3.8)
Route 42 (2.0) Podophyllotoxin 113 (3.4) Cytotoxicity 194 (3.7)February 2020 | Volume 11 | Article 37
Yeung et al. Lignans: Quantitative Analysis of the Research Literaturelariciresinol, matairesinol, pinoresinol, secoisolariciresinol,
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